Ashley Gary W, Burlingame Mark, Desai Ruchir, Fu Hong, Leaf Tim, Licari Peter J, Tran Chau, Abbanat Darren, Bush Karen, Macielag Mark
Kosan Biosciences, Inc., 3832, Bay Center Place, Hayward, California 94545, USA.
J Antibiot (Tokyo). 2006 Jul;59(7):392-401. doi: 10.1038/ja.2006.56.
Chemobiosynthesis has been used to prepare analogs of erythromycins having unique functional groups at the 15-position. Using diketide thioester feeding to genetically engineered Streptomyces coelicolor, analogs of 6-deoxyerythronolide B were prepared having 15-fluoro, 15-chloro, and 15-azido groups. Bioconversion using a genetically engineered mutant of Saccharopolyspora erythraea was used to produce 15-fluoroerythromycin A and 15-azidoerythromycin A. These new erythromycin analogs provide antibacterial macrolides with unique physicochemical properties and functional groups that allow for selective derivatization.
化学合成已被用于制备在15位具有独特官能团的红霉素类似物。通过向基因工程改造的天蓝色链霉菌中添加二酮硫酯,制备了具有15-氟、15-氯和15-叠氮基的6-脱氧红霉内酯B类似物。利用基因工程改造的糖多孢红霉菌突变体进行生物转化,生产出15-氟红霉素A和15-叠氮基红霉素A。这些新型红霉素类似物提供了具有独特物理化学性质和官能团的抗菌大环内酯类药物,可实现选择性衍生化。